Food And Drug Administration, United States, JOY discussed on The John Phillips Show


US HDTV Los Angeles Next round in the battle against the pandemic is underway and distribution of a covert 19 vaccine has begun across the United States. The Food and Drug Administration commissioner says he's hopeful the first Corona virus vaccine will be administered by tomorrow. On CNN's state of the union, Dr. Stephen Hahn claims no outside comments or pressure were applied to any decisions made about the vaccine. We have been very clear that nothing guided our decision, no external comments, no external pressure other than the science and data guided our decision making on insists the target of having 20 million doses available by the end of the year. Is realistic. It's possible certainly heard those discussions and I think that's a reasonable prediction. And I have confidence around that assistant nursing professor at U C L. A. Says she got the covert vaccine. And experienced severe side effects. Kristen Choice says they showed up after the booster shot had chills, nausea, fatigue, headache the day after that vaccine on Ben that evening, I started to develop a fever, and that kind of escalated overnight. I woke up the next morning with a very high fever. Joy took part in the Fizer vaccine trials and sauce. Symptoms come and go over the course of a day. She says. The good news is that most people will not experience symptoms, and if they do, they'll go away. I'm at Madison by in Tech is ramping up production of its Corona virus vaccine. The German company that developed a vaccine in partnership with Visor is getting ready to meet the demand Now that the U. S. Food and Drug Administration's emergency use approval has been issued, Reuters reported that by on Tech CEO or in Sheheen says the company is looking into different ways to make more vaccine within anticipated production next year of 1.3. Billion doses needed. I'm Lisa Taylor. I'm Cameron Fairchild. Get it. Get it Right. Talk Radio 7 90 K ABC News 12 03 I am Tom. Loony.

Coming up next